GABRA3 antisense RNA 1 (GABRA3-AS1)

GABRA3 antisense RNA 1 (GABRA3-AS1) refers to a predicted or putative long non-coding RNA (lncRNA) transcribed antisense to the GABRA3 gene locus. The available search results do not provide specific information on its sequence, function, or biomedical significance. Antisense RNAs in general may regulate expression of their sense counterpart by mechanisms involving transcriptional interference, RNA-RNA interactions, or guiding epigenetic modifications, as shown in other genes (e.g., CDR1 antisense RNA)[3]. No evidence exists in the current biomedical literature establishing GABRA3-AS1 as a therapeutic target, disease biomarker, or druggable entity. The vast majority of research and drug development regarding “GABRA3” is focused on the GABA_A receptor alpha3 subunit, a protein involved in neurotransmission and cancer, not the antisense RNA[1][4][5]. In databases or literature, “GABRA3-AS1” may be misattributed as a protein or receptor target, but it is most likely a non-coding RNA with no established biological or therapeutic relevance.

None known; no mechanism of action described for drugs targeting this molecule.